Matches in SemOpenAlex for { <https://semopenalex.org/work/W2801529820> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W2801529820 endingPage "255" @default.
- W2801529820 startingPage "245" @default.
- W2801529820 abstract "This study evaluated the pharmacokinetics (PK), efficacy, safety, and tolerability of bleselumab - a fully-human anti-CD40 monoclonal recombinant IgG4. Patients with moderate-to-severe psoriasis were randomized on day 1 to receive bleselumab or placebo on days 1, 15 and 29 in a dose-escalation of bleselumab at 0.1, 0.3, 1.0 or 3.0 mg/kg. The safety-analysis set (SAF) and full-analysis set (FAS) included all patients who received bleselumab or placebo, and the PK-analysis set (PKAS) included patients in the SAF with ≥1 quantifiable serum bleselumab concentration. Serial blood samples were collected after each dose, and the bleselumab serum concentration was measured. After each dose, the area-under-the-concentration-time curve over 336 hours (AUC336 ) and the maximum serum concentration (Cmax ), and dose proportionality of AUC336 and Cmax were determined. The psoriasis area and severity index (PASI) score, the physician static global assessment (PSGA) score, the percentage body surface area (%BSA) affected with psoriasis, adverse events and laboratory parameters were assessed. Sixty patients were randomized and included in the SAF/FAS (bleselumab, n = 49; placebo, n = 11); 48 formed the PKAS. Bleselumab Cmax and AUC336 were more than dose proportional in the range 0.1-3.0 mg/kg, suggesting nonlinear PK after single/multiple doses. No clinically significant infusion reactions, cytokine-release syndrome, or thromboembolic events were reported. Bleselumab did not improve the PASI scores, PSGA scores, or %BSA versus placebo. Transient elevation of alanine aminotransferase and aspartate aminotransferase levels by >3 × upper limit of normal were observed in four (8.2%) and two (4.1%) patients, respectively, in the 1.0 or 3.0 mg/kg groups. Patients with liver function test increases had no concurrent changes in bilirubin. Bleselumab demonstrated nonlinear PK after single and multiple doses, with few adverse reactions." @default.
- W2801529820 created "2018-05-17" @default.
- W2801529820 creator A5008286260 @default.
- W2801529820 creator A5018226716 @default.
- W2801529820 creator A5028045704 @default.
- W2801529820 creator A5030204314 @default.
- W2801529820 creator A5056026206 @default.
- W2801529820 creator A5066740563 @default.
- W2801529820 creator A5088419560 @default.
- W2801529820 date "2018-04-21" @default.
- W2801529820 modified "2023-10-13" @default.
- W2801529820 title "Randomized, controlled study of bleselumab (ASKP1240) pharmacokinetics and safety in patients with moderate-to-severe plaque psoriasis" @default.
- W2801529820 cites W1517398753 @default.
- W2801529820 cites W1528086703 @default.
- W2801529820 cites W1528492996 @default.
- W2801529820 cites W1566149917 @default.
- W2801529820 cites W1585519602 @default.
- W2801529820 cites W1963627597 @default.
- W2801529820 cites W1989232610 @default.
- W2801529820 cites W1999908488 @default.
- W2801529820 cites W2005725688 @default.
- W2801529820 cites W2008086119 @default.
- W2801529820 cites W2012027479 @default.
- W2801529820 cites W2021018799 @default.
- W2801529820 cites W2024531319 @default.
- W2801529820 cites W2034350610 @default.
- W2801529820 cites W2055018575 @default.
- W2801529820 cites W2059791530 @default.
- W2801529820 cites W2061142243 @default.
- W2801529820 cites W2068225706 @default.
- W2801529820 cites W2083764534 @default.
- W2801529820 cites W2104874866 @default.
- W2801529820 cites W2116526448 @default.
- W2801529820 cites W2290515360 @default.
- W2801529820 cites W2327649147 @default.
- W2801529820 cites W2767735239 @default.
- W2801529820 doi "https://doi.org/10.1002/bdd.2130" @default.
- W2801529820 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6032846" @default.
- W2801529820 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29679478" @default.
- W2801529820 hasPublicationYear "2018" @default.
- W2801529820 type Work @default.
- W2801529820 sameAs 2801529820 @default.
- W2801529820 citedByCount "22" @default.
- W2801529820 countsByYear W28015298202019 @default.
- W2801529820 countsByYear W28015298202020 @default.
- W2801529820 countsByYear W28015298202021 @default.
- W2801529820 countsByYear W28015298202022 @default.
- W2801529820 crossrefType "journal-article" @default.
- W2801529820 hasAuthorship W2801529820A5008286260 @default.
- W2801529820 hasAuthorship W2801529820A5018226716 @default.
- W2801529820 hasAuthorship W2801529820A5028045704 @default.
- W2801529820 hasAuthorship W2801529820A5030204314 @default.
- W2801529820 hasAuthorship W2801529820A5056026206 @default.
- W2801529820 hasAuthorship W2801529820A5066740563 @default.
- W2801529820 hasAuthorship W2801529820A5088419560 @default.
- W2801529820 hasBestOaLocation W28015298201 @default.
- W2801529820 hasConcept C112705442 @default.
- W2801529820 hasConcept C126322002 @default.
- W2801529820 hasConcept C16005928 @default.
- W2801529820 hasConcept C168563851 @default.
- W2801529820 hasConcept C2780564577 @default.
- W2801529820 hasConcept C3020604521 @default.
- W2801529820 hasConcept C71924100 @default.
- W2801529820 hasConcept C98274493 @default.
- W2801529820 hasConceptScore W2801529820C112705442 @default.
- W2801529820 hasConceptScore W2801529820C126322002 @default.
- W2801529820 hasConceptScore W2801529820C16005928 @default.
- W2801529820 hasConceptScore W2801529820C168563851 @default.
- W2801529820 hasConceptScore W2801529820C2780564577 @default.
- W2801529820 hasConceptScore W2801529820C3020604521 @default.
- W2801529820 hasConceptScore W2801529820C71924100 @default.
- W2801529820 hasConceptScore W2801529820C98274493 @default.
- W2801529820 hasIssue "5" @default.
- W2801529820 hasLocation W28015298201 @default.
- W2801529820 hasLocation W28015298202 @default.
- W2801529820 hasLocation W28015298203 @default.
- W2801529820 hasOpenAccess W2801529820 @default.
- W2801529820 hasPrimaryLocation W28015298201 @default.
- W2801529820 hasRelatedWork W1562137081 @default.
- W2801529820 hasRelatedWork W1913268257 @default.
- W2801529820 hasRelatedWork W2304037606 @default.
- W2801529820 hasRelatedWork W2325746433 @default.
- W2801529820 hasRelatedWork W2404038155 @default.
- W2801529820 hasRelatedWork W4233478162 @default.
- W2801529820 hasRelatedWork W4238761345 @default.
- W2801529820 hasRelatedWork W4250984372 @default.
- W2801529820 hasRelatedWork W4305072823 @default.
- W2801529820 hasRelatedWork W2467538956 @default.
- W2801529820 hasVolume "39" @default.
- W2801529820 isParatext "false" @default.
- W2801529820 isRetracted "false" @default.
- W2801529820 magId "2801529820" @default.
- W2801529820 workType "article" @default.